MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.bbmt.2013.07.005

Медицинская библиотека · Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2013

Specific features identify patients with relapsed or refractory mantle cell lymphoma benefitting from autologous hematopoietic cell transplantation.

Cassaday Ryan D, Guthrie Katherine A, Budde Elizabeth L, Thompson Leslie, Till Brian G, Press Oliver W, Chauncey Thomas R, Pagel John M, Petersdorf Stephen H, Palanca-Wessels Maria Corinna, Philip Mary, Bensinger William I, Holmberg Leona A, Shustov Andrei, Green Damian J, Libby Edward N, Maloney David G, Gopal Ajay K

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Outcomes with autologous hematopoietic cell transplantation (auto HCT) for relapsed and/or refractory mantle cell lymphoma (MCL) are typically poor. We hypothesized that certain factors could predict which patients experience a favorable outcome with this approach. We thus developed a predictive score from a cohort of 67 such patients using 3 factors independently associated with progression-free survival (PFS): (1) simplified Mantle Cell Lymphoma International Prognostic Index score before auto HCT (hazard ratio [HR], 2.9; P = .002); (2) B symptoms at diagnosis (HR, 2.7; P = .005); and (3) remission quotient, calculated by dividing the time, in months, from diagnosis to auto HCT by the number of prior treatments (HR, 1.4; P = .02). The estimated 5-year PFS for favorable-risk patients (n = 23) and unfavorable-risk patients (n = 44) were 58% (95% confidence interval [CI], 34% to 75%) and 15% (95% CI, 6% to 28%), respectively. These factors also independently predicted overall survival. In summary, we have defined 3 simple factors that can identify patients with relapsed/refractory MCL who derive a durable benefit from salvage auto HCT.

Для цитирования: Cassaday Ryan D, Guthrie Katherine A, Budde Elizabeth L, Thompson Leslie, Till Brian G, Press Oliver W, Chauncey Thomas R, Pagel John M, Petersdorf Stephen H, Palanca-Wessels Maria Corinna, Philip Mary, Bensinger William I, Holmberg Leona A, Shustov Andrei, Green Damian J, Libby Edward N, Maloney David G, Gopal Ajay K. Specific features identify patients with relapsed or refractory mantle cell lymphoma benefitting from autologous hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2013. DOI: 10.1016/j.bbmt.2013.07.005.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.